Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01102088 · ClinicalTrials.gov registry record · Phase 1
Simultaneous Integrated Boost (SIB) in Esophageal Cancer
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 61
- Enrollment target
NCT01102088: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT01102088 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01102088, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 61 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find the highest tolerable dose of radiation that can be given in combination with chemotherapy in patients with esophageal cancer that cannot be removed by surgery.
Interventions
- RADIATION Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2010-04 |
| Est. Completion | 2019-06-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01102088
The ClinicalTrials.gov registry entry for NCT01102088 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT01102088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01102088 about?
NCT01102088 is a clinical study titled "Simultaneous Integrated Boost (SIB) in Esophageal Cancer". The goal of this clinical research study is to find the highest tolerable dose of radiation that can be given in combination with chemotherapy in patients with esophageal cancer that cannot be removed by surgery.
What is the current status of trial NCT01102088?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 61 participants. The study started on 2010-04. Estimated completion is 2019-06-08.
What interventions are being tested in trial NCT01102088?
The interventions under investigation include: Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT01102088?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.